Verstraeten RA - Search Results

1

Oncogenic pathways in hereditary and sporadic breast cancer.

Kenemans P, Verstraeten RA, Verheijen RH. Kenemans P, et al. Among authors: verstraeten ra. Maturitas. 2004 Sep 24;49(1):34-43. doi: 10.1016/j.maturitas.2004.06.005. Maturitas. 2004. PMID: 15351094 Review.

2

Quantification of MUC1 in breast cancer patients. A method comparison study.

Bon GG, van Kamp GJ, Verstraeten RA, von Mensdorff-Pouilly S, Hilgers J, Kenemans P. Bon GG, et al. Among authors: verstraeten ra. Eur J Obstet Gynecol Reprod Biol. 1999 Mar;83(1):67-75. doi: 10.1016/s0301-2115(98)00302-9. Eur J Obstet Gynecol Reprod Biol. 1999. PMID: 10221613

3

Clinical and technical evaluation of ACS BR serum assay of MUC1 gene-derived glycoprotein in breast cancer, and comparison with CA 15-3 assays.

Bon GG, von Mensdorff-Pouilly S, Kenemans P, van Kamp GJ, Verstraeten RA, Hilgers J, Meijer S, Vermorken JB. Bon GG, et al. Among authors: verstraeten ra. Clin Chem. 1997 Apr;43(4):585-93. Clin Chem. 1997. PMID: 9105258

4

Influence of chemotherapy on the expression of p53, HER-2/neu and proliferation markers in ovarian cancer.

Nijman HW, Kenemans P, Poort-Keesom RJ, Verstraeten RA, Mensdorff-Pouilly S, Verheijen RH, Melief CJ, Hilgers J, Meijer CJ. Nijman HW, et al. Among authors: verstraeten ra. Eur J Obstet Gynecol Reprod Biol. 1999 Apr;83(2):201-6. doi: 10.1016/s0301-2115(98)00317-0. Eur J Obstet Gynecol Reprod Biol. 1999. PMID: 10391533

5

Oncogenic pathways in hereditary and sporadic breast cancer.

Kenemans P, Verstraeten RA, Verheijen RH. Kenemans P, et al. Among authors: verstraeten ra. Maturitas. 2008 Sep-Oct;61(1-2):141-50. doi: 10.1016/j.maturitas.2008.11.010. Maturitas. 2008. PMID: 19434886

6

T cell infiltration and MHC I and II expression in the presence of tumor antigens: An immunohistochemical study in patients with serous epithelial ovarian cancer.

Nijman HW, van Diest PJ, Poort-Keesom RJ, von Mensdorff-Pouilly S, Verstraeten RA, Kummer A, Meijer CJ, Melief CJ, Hilgers J, Kenemans P. Nijman HW, et al. Among authors: verstraeten ra. Eur J Obstet Gynecol Reprod Biol. 2001 Jan;94(1):114-20. doi: 10.1016/s0301-2115(00)00294-3. Eur J Obstet Gynecol Reprod Biol. 2001. PMID: 11134836

7

Clinical and technical evaluation of the ACS:OV serum assay and comparison with three other CA125-detecting assays.

Davelaar EM, Schutter EM, von Mensdorff-Pouilly S, van Kamp GJ, Verstraeten RA, Kenemans P. Davelaar EM, et al. Among authors: verstraeten ra. Ann Clin Biochem. 2003 Nov;40(Pt 6):663-73. doi: 10.1258/000456303770367270. Ann Clin Biochem. 2003. PMID: 14629806

8

Cellular and humoral responses after multiple injections of unconjugated chimeric monoclonal antibody MOv18 in ovarian cancer patients: a pilot study.

van Zanten-Przybysz I, Molthoff C, Gebbinck JK, von Mensdorff-Pouilly S, Verstraeten R, Kenemans P, Verheijen R. van Zanten-Przybysz I, et al. J Cancer Res Clin Oncol. 2002 Sep;128(9):484-92. doi: 10.1007/s00432-002-0348-z. Epub 2002 Aug 23. J Cancer Res Clin Oncol. 2002. PMID: 12242512 Clinical Trial.

9

CA 125 serum levels in the early post-operative period do not reflect tumour reduction obtained by cytoreductive surgery.

Yedema CA, Kenemans P, Thomas CM, Massuger LF, Wobbes T, Verstraeten R, van Kamp GJ, Hilgers J. Yedema CA, et al. Eur J Cancer. 1993;29A(7):966-71. doi: 10.1016/s0959-8049(05)80203-5. Eur J Cancer. 1993. PMID: 8499150

10

Reproducibility of saline contrast sonohysterography for the detection of intracavitary abnormalities in women with abnormal uterine bleeding.

Beemsterboer SN, Thurkow AL, Verstraeten R, Brölmann HA. Beemsterboer SN, et al. Ultrasound Obstet Gynecol. 2008 Apr;31(4):445-9. doi: 10.1002/uog.5287. Ultrasound Obstet Gynecol. 2008. PMID: 18383471

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results